Clinical Evaluation of FreeO2 (Version 4) in All Patients Receiving Oxygen

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-30

Study Completion Date

2020-11-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of automatic titration of oxygen with a new version of FreeO2 (V4)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)

NCT04320056

Coronavirus Pneumonia Oxygen Toxicity

UNKNOWN NA

Comparison of Two Oxygenation Targets With Two Different Oximeters - Impact on Oxygen Flow Rates and Oxygenation

NCT05590130

Oxygen Toxicity Respiratory Failure

RECRUITING NA

Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy

NCT07168213

Oxygen Delivery Acute Respiratory Failure High Flow Oxygen Therapy +1 more

NOT_YET_RECRUITING NA

Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

NCT03527992

Pneumonia Pneumonia, Ventilator-Associated Length of Stay

RECRUITING NA

Pulmonary Function After Hyperbaric Oxygen Therapy

NCT05088772

Oxygen Toxicity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the previous studies, the investigators used many times automatic titration of oxygen on spontanous breathing patient (FreeO2 device) with a prototype develop in our lab in collaboration with Laval university. In this study, we want to evaluate the new version of the FreeO2 device (V4)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Disease Respiratory Failure COPD Exacerbation Asthma Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Automated oxygen adjustment

All patient in this study have automatic oxygen titration and automatic oxygen weanning

Group Type OTHER

FreeO2

Intervention Type DEVICE

All include patients will have automatic administration of oxygen by FreeO2 up to 3 day or until weaning of oxygen adminisatrion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FreeO2

All include patients will have automatic administration of oxygen by FreeO2 up to 3 day or until weaning of oxygen adminisatrion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> or = 18 years old
* Patient receiving oxygen between 1 to 6 lpm for medical pathology
* Admitted to a medical service for less than 72 hours (emergency room not included)

Exclusion Criteria

* Unreliable SpO2 signal
* Emergency or intensive care hospitalization
* Absence of NIV or intubation criteria at baseline
* Sleep apnea not paired
* Long-term Oxygen Therapy
* Active delirium and cognitive impairment preventing informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No